Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

Abstract Adjuvant chemotherapy improves breast cancer survival but is associated with bothersome short- and long-term toxicity. Factors associated with toxicity, especially subacute toxicity up to 2 years following chemotherapy, have not been fully elucidated. The NRG Oncology/NSABP B-30 clinical tr...

Full description

Bibliographic Details
Main Authors: N. Lynn Henry, Sungjin Kim, Ron D. Hays, Marcio A. Diniz, Mourad Tighiouart, Gillian Gresham, Michael Luu, Reena S. Cecchini, Greg Yothers, André Rogatko, Patricia A. Ganz
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-022-00489-9

Internet

https://doi.org/10.1038/s41523-022-00489-9

Similar Items